Vital IV Infusions Offers Ketamine Infusions for Depression Treatment in Chatham, NJ
Over 17 million American adults deal with the symptoms of major depression in any given year.
Many people find themselves managing treatment-resistant depression – a kind of depression that does not respond to multiple attempts at finding relief. If psychotherapy or antidepressants didn’t help you or a loved one manage depression symptoms, ketamine infusion therapy may be the answer you’ve been looking for.
What is Depression?
Although everyone feels sadness as part of the normal emotional spectrum, depression itself is a mental health condition that affects everyday life in a more intense way. Apart from the often-overbearing sadness, it can include a tendency to isolate oneself and step away from responsibilities. Normal day-to-day tasks can become increasingly difficult to perform.
The important thing to remember is that depression is no one’s fault – it’s the result of changes to the brain from trauma, chemical imbalances, or genetic differences. Even treatment-resistant depression can be relieved with the right options, like those provided here at Vital IV Infusions.
What Are The Symptoms of Depression?
- Feelings of hopelessness or emptiness
- Unexplained physical aches
- Bouts of tearfulness
- Mood swings
- Angry outbursts
- Fatigue or trouble sleeping
- Appetite or weight changes
- Slowed thinking or body movements
How Does Ketamine Help Depression?
Ketamine targets NMDA receptors inside of the brain. By connecting to these receptors, ketamine can amplify the amount of glutamate inside the space between the neurons.
Glutamate then binds to the AMPA receptors – receptors that are often deactivated or weakened in the brains of people with depression. After ketamine infusions, these receptors may be able to turn back on.
At Vital IV Infusions, we offer low-dose ketamine infusions for depression treatment in Chatham, NJ.
- Getting the Inside Dope on Ketamine’s Mysterious Ability to Rapidly Relieve Depression – Scientific American (March 2018)
- Intravenous Ketamine for Adolescents with Treatment-Resistant Depression: An Open-Label Study – Journal of Child and Adolescent Psychopharmacology (July 2018)
- Ketamine for Rapid Reduction of Suicidal Thoughts in Major Depression – American Journal of Psychiatry (Dec 2017)
- World-First Ketamine Trial Shows Promise For Geriatric Depression – American Journal of Geriatric Psychiatry (July 2017)
- FDA Data Support Ketamine as Depression Therapy – MedPage Today (May 2017)
- How Ketamine Infusion Will Transform the Way Depression is Treated – The Doctor Weighs In (July 2017)
- Club Drug Ketamine Gains Traction As A Treatment For Depression – NPR.org (Sept 2015)
- Ketamine may be quick, effective treatment for untreatable depression – CBS News (May 2013)
- The Role of Ketamine in Treatment-Resistant Depression: A Systematic Review – National Center for Biotechnology Information (Sept 2014)